Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-01-11FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for sotalol hydrochloride, confirming approval of a generic product. …
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: Effect of Structural Remodeling on Scar Formation as Assessed by DE-MRI of the Left Atrium
A completed trial evaluated how structural remodeling affects scar formation in the left atrium, using delayed-enhancement MRI, with results…
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: The Simple ECG Monitoring Trial (Comparison of a Novel Recording System With a Standard Holter Monitor)
This trial compared a novel ECG recording system with a standard Holter monitor to evaluate arrhythmia detection. The study, conducted in pa…
-
FDA approval · 2011-12-30FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin (DIGOXIN) from Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS research · 2011-12-30Clinical Trial Update: A Retrospective Register Study to Map the Frequency of Short Duration Atrial Fibrillation (AF) Among All Patients Admitted to Roskilde Sygehus in Denmark in 2010
This clinical trial update reports a retrospective register study to map the frequency of short-duration atrial fibrillation among all patie…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: Detection of Occult Paroxysmal Atrial Fibrillation After Stroke Using Prolonged Ambulatory Cardiac Monitoring
Completed clinical trial update on detecting occult paroxysmal atrial fibrillation after stroke using prolonged ambulatory cardiac monitorin…
-
FDA label_change · 2011-12-19FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Multaq (dronedarone) submitted by Sanofi-Aventis U.S. LLC, resulting in labeling updates for…
-
FDA approval · 2011-12-12FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) from Baxter Healthcare Company.
-
FDA approval · 2011-11-29FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Verapamil Hydrochloride from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery [Phase 4]
A Phase 4 trial comparing intravenous metoprolol to intravenous amiodarone for preventing postoperative atrial fibrillation after cardiac su…
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Prognostic Indicators as Provided by the EPIC ClearView
A completed clinical trial update from EPIC ClearView describing prognostic indicators across several conditions.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Atrial Tissue Banking: Atrial Tissue Obtained From Patients Undergoing Heart Surgery
The clinical trial NCT00248274 on atrial tissue banking from patients undergoing heart surgery was terminated.
-
FDA approval · 2011-11-18FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc., authorizing changes to the product's labeling. …
-
EMA safety_alert · 2011-11-18European Medicines Agency updates on safety of Pradaxa
EMA updates safety information for Pradaxa (dabigatran) to reflect new risk signals and recommendations for monitoring and use.
-
FDA approval · 2011-11-14FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Advanz Pharma (US) Corp., corresponding to a labeling update …
-
FDA approval · 2011-11-14FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for LANOXIN (digoxin) from Covis Pharma US, Inc., likely resulting in labeling updates for the produ…
-
FDA approval · 2011-11-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
FDA approved a supplemental application for Verapamil hydrochloride submitted by Teva Pharmaceuticals Inc. This action finalizes changes to …
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE) [Phase 4]
This clinical trial update reports the Phase 4 AFRODITE study evaluating whether adding dronedarone to standard rate-control therapy affects…
-
FDA approval · 2011-11-02FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
FDA approved a supplemental NDA for Verapamil Hydrochloride from Exela Pharma Sciences, LLC under NDA 018925.
-
FDA approval · 2011-10-28FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for CARTIA XT (diltiazem hydrochloride) under ANDA074752.
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation. [Phase 3]
Phase 3 trial comparing azimilide and sotalol to placebo in patients with atrial fibrillation to evaluate efficacy and safety; the study has…
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation [Phase 3]
Phase 3 trial evaluating azimilide for atrial fibrillation has completed. The update reports on its efficacy and safety in these patients.
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation. [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Azimilide for prophylaxis of atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: CONTAK RENEWAL 3 AVT [Phase 3]
Phase 3 clinical trial CONTAK RENEWAL 3 AVT by Boston Scientific has completed. The study investigated effects in heart failure and atrial f…
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study [Phase 4]
Phase 4 post-marketing trial evaluating heart rate regularization in patients with permanent atrial fibrillation has completed and posted re…